Watchlist Price Alert

Annovis Bio Inc. (ANVS)

NYSE: ANVS · Real-Time Price · USD

1.99

-0.09 (-4.33%)

At close: May 23, 2025, 3:59 PM

1.98

-0.52%

After-hours: May 23, 2025, 05:24 PM EDT

Annovis Bio Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Net Income	-24.59B	-56.2M	-25.33M	-14.49M	-5.46M	-990.98K	-713.87K	-682.35K
Depreciation & Amortization	n/a	n/a	n/a	n/a	129K	1.19M	n/a	n/a
Stock-Based Compensation	3.84B	4.63M	9.15M	4.7M	1.86M	8.48K	82.73K	48.49K
Other Working Capital	-331.43K	2.44M	-4.41M	311.13K	294.95K	-547.57K	75.22K	34.55K
Other Non-Cash Items	-1.14B	9.17M	5.88M	4.35M	27.02K	84.43K	85.41K	11.58K
Deferred Income Tax	n/a	n/a	n/a	n/a	-129K	-1.19M	n/a	n/a
Change in Working Capital	681.71K	2.44M	-1.14M	657.35K	-400.71K	421.53K	72.53K	96.37K
Operating Cash Flow	-21.89B	-39.97M	-17.31M	-9.13M	-3.97M	-476.54K	-558.61K	-537.48K
Capital Expenditures	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Debt Repayment	n/a	n/a	n/a	n/a	n/a	530K	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	26.67B	458.38K	4.61K	95.1K	9.22K	-86.91K	246.45K	332.5K
Financial Cash Flow	26.69B	17.34M	4.61K	46.74M	12.04M	443.09K	246.45K	332.5K
Net Cash Flow	4.8B	-22.62M	-17.31M	37.61M	8.07M	-33.45K	-312.16K	-204.99K
Free Cash Flow	-21.89B	-39.97M	-17.31M	-9.13M	-3.97M	-476.54K	-558.61K	-537.48K